Pacifica Partners Inc. - LINEAGE CELL THERAPEUTICS IN ownership

Back to all holdings Add to watchlist

LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 90 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Pacifica Partners Inc. ownership history of LINEAGE CELL THERAPEUTICS IN
ValueSharesWeighting
Q4 2023$2,926
-23.7%
2,9260.0%0.00%
-50.0%
Q3 2023$3,833
-3.0%
2,9260.0%0.00%0.0%
Q2 2023$3,950
-2.5%
2,9260.0%0.00%0.0%
Q1 2023$4,050
+31.7%
2,9260.0%0.00%0.0%
Q4 2022$3,075
-23.1%
2,9260.0%0.00%
-33.3%
Q3 2022$4,0000.0%2,9260.0%0.00%0.0%
Q2 2022$4,0000.0%2,9260.0%0.00%0.0%
Q1 2022$4,000
-33.3%
2,9260.0%0.00%
-25.0%
Q4 2021$6,000
-25.0%
2,9260.0%0.00%
-33.3%
Q3 2021$8,0000.0%2,9260.0%0.01%0.0%
Q2 2021$8,000
+14.3%
2,9260.0%0.01%0.0%
Q1 2021$7,000
+40.0%
2,9260.0%0.01%
+20.0%
Q4 2020$5,000
+66.7%
2,9260.0%0.01%
+66.7%
Q3 2020$3,000
+50.0%
2,9260.0%0.00%
+50.0%
Q2 2020$2,0000.0%2,9260.0%0.00%0.0%
Q1 2020$2,000
-33.3%
2,9260.0%0.00%
-33.3%
Q4 2019$3,000–2,926–0.00%–
 Download
Other shareholders
LINEAGE CELL THERAPEUTICS IN shareholders Q4 2020
NameSharesValueWeighting ↓
Defender Capital, LLC. 4,735,990$8,335,0003.63%
BROADWOOD CAPITAL INC 34,005,379$59,849,0003.55%
Prescott General Partners LLC 1,851,851$3,259,0000.14%
Strategic Wealth Investment Group, LLC 66,917$118,0000.07%
Laidlaw Wealth Management LLC 170,658$300,0000.06%
Humankind Investments LLC 26,737$47,0000.05%
DAFNA Capital Management LLC 80,000$141,0000.04%
Beirne Wealth Consulting Services, LLC 45,000$79,0000.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 680,839$1,198,0000.02%
Allegheny Financial Group LTD 20,000$35,0000.02%
View complete list of LINEAGE CELL THERAPEUTICS IN shareholders